Growth charts for patients affected with Morquio A disease.
about
Role of elosulfase alfa in mucopolysaccharidosis IVAMorquio A syndrome-associated mutations: a review of alterations in the GALNS gene and a new locus-specific databaseHematopoietic stem cell transplantation for Morquio A syndrome.Current and emerging treatments and surgical interventions for Morquio A syndrome: a reviewDiagnosis of Morquio-A patients in Mexico: How far are we from prompt diagnosis?Growth charts for patients with Hunter syndrome.Growth patterns and the use of growth hormone in the mucopolysaccharidoses.Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.Orthopedic management of the extremities in patients with Morquio A syndrome.Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutationsChondroitin 6-Sulfate as a Novel Biomarker for Mucopolysaccharidosis IVA and VII.Anthropometric characteristics of four Polish children with mucopolysaccharidosis.Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA.Glycosaminoglycan storage disorders: a reviewDi-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)Safety and clinical activity of elosulfase alfa in pediatric patients with Morquio A syndrome (mucopolysaccharidosis IVA) less than 5 y.Clinical, radiologic, and genetic features of Korean patients with Mucopolysaccharidosis IVA.Non-invasive pulmonary function test on Morquio patientsObstructive airway in Morquio A syndrome, the past, the present and the future.Review of clinical presentation and diagnosis of mucopolysaccharidosis IVAMucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.Activity of daily living for Morquio A syndrome.Mucopolysaccharidosis IVA and glycosaminoglycans.Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI.Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome).Optimizing the molecular diagnosis of GALNS: novel methods to define and characterize Morquio-A syndrome-associated mutations.Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).Subjective and Objective Assessment of Hand Function in Mucopolysaccharidosis IVa Patients.30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: About one case.Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine.Oxidative profile exhibited by Mucopolysaccharidosis type IVA patients at diagnosis: Increased keratan urinary levels.Growth patterns in children with mucopolysaccharidosis I and II.Natural history of Morquio A patient with tracheal obstruction from birth to death.Combined spinal arthrodesis with instrumentation for the management of progressive thoracolumbar kyphosis in children with mucopolysaccharidosis.Neurophysiology of hearing in patients with mucopolysaccharidosis type IV.International guidelines for the management and treatment of Morquio A syndrome.Five novel mutations of GALNS in Korean patients with mucopolysaccharidosis IVA.Mucopolysaccharidosis IVA mutations in Chinese patients: 16 novel mutations.Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA.
P2860
Q26745750-75F3B759-41B7-46A2-BA73-30A4D728D415Q26824085-3BEED4B9-4833-42CF-9B89-D9FD3722A104Q30809579-583733B6-9F7F-411E-92F7-4556774DD7C6Q33610398-BD85F553-865C-447B-A4B6-2148689D0160Q33747881-526EBE3D-8710-48C8-A5AE-7894E7F41172Q33768712-F7C5508C-0827-4032-8D29-29338A45173BQ33918468-03EB706F-B7B0-4C5F-AE41-E3ACAF3F6C0BQ33995906-460EF7F0-5364-48B7-83E1-D01F6E0B17B7Q34028791-593D08AB-CF40-4B10-87F9-CB676B61F52DQ34373560-FB2B2152-38FE-4BB2-8279-6BBA47621883Q34459501-5810A8B0-4DD7-48CA-B1D8-16BC52AF503AQ34788370-EDD8E413-646E-4B37-B587-DF14E2F7AF7BQ34938821-243B7DC5-48A3-4D34-84A5-039038125761Q35367599-7069C788-B871-491A-8422-43067E2CEC9CQ35752500-AB5478FE-34C5-4114-8F46-45DED8D55A44Q36127763-B05EB7E1-91B5-4250-A14B-2E17B3D81361Q36426886-9413929D-6AB7-439A-98E7-26E08B450F25Q36434254-E3D0B055-2B0E-49DA-B66B-5E114A952426Q36445773-90364D59-10CC-4BC4-B7B9-5520A5B8CE4DQ36586406-026071EC-4767-4725-B651-3C78478407F4Q37126295-03B23B0F-E0F7-4473-97C7-4D9B9FD2B71FQ37189808-A019132B-1D3E-4CE2-BA1C-D964CCB35A67Q37243265-38D8D380-98B9-4BBE-A18A-34EFF70FB14AQ37626886-F285E060-06D8-4555-A0F8-E112A4E65CD8Q37686034-2053CB9E-81C6-4F23-B4B7-0A3B4CDEBB9EQ38794433-6F558930-EEF5-42A6-A1C1-8042B1125A24Q38924874-664130A9-EBE7-44F9-93D9-AF2113EC3F56Q39323860-09427069-A53B-49FA-89A5-ACC879F6FC37Q39463442-8D3315AB-A94B-4DE2-BEB0-1BA37F169F82Q41466662-FEBEE720-D42B-4CD4-AD2D-CCCA4B62A289Q42131304-046A29D6-4A86-44EE-B604-1842CC024CCCQ42290266-5D632F9F-3C76-4D8B-B67E-E96184A0C616Q47587025-B1641096-D492-41AD-B249-BEFEF2F02F77Q47658772-F1D41F02-ACC8-4107-8C2E-D22B06038FC0Q48892663-8CF44CEC-9F49-42E4-8B21-8F81B983A995Q50300965-92AF5822-31B1-47A4-9058-8714EEB60058Q53082504-FE9C669E-A7A5-4311-A42D-F3D6B8A7FCBDQ53341440-2A5BCFF6-8294-434E-8B33-50B5B02C2C8FQ54422759-2B42864C-FA75-4547-BEDC-66C8E380E5EBQ55425884-046D9C28-4B58-46DA-86ED-EB885B091124
P2860
Growth charts for patients affected with Morquio A disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Growth charts for patients affected with Morquio A disease.
@en
Growth charts for patients affected with Morquio A disease.
@nl
type
label
Growth charts for patients affected with Morquio A disease.
@en
Growth charts for patients affected with Morquio A disease.
@nl
prefLabel
Growth charts for patients affected with Morquio A disease.
@en
Growth charts for patients affected with Morquio A disease.
@nl
P2093
P2860
P356
P1476
Growth charts for patients affected with Morquio A disease.
@en
P2093
Adriana M Montaño
Ana Brusius
Mary Smith
Shunji Tomatsu
Tadao Orii
P2860
P304
P356
10.1002/AJMG.A.32281
P407
P577
2008-05-01T00:00:00Z